Hepatitis B Virus Reactivation in Kidney Transplant Recipients Treated With Belatacept

Chloë Schwarz,Antoine Morel,Marie Matignon,Philippe Grimbert,Eric Rondeau,Nacera Ouali,Hélène François,Laurent Mesnard,Camille Petit-Hoang,Cédric Rafat,Karine Dahan,Yosu Luque

Nephrology Dialysis Transplantation（2023）

引用 0|浏览23

暂无评分

摘要

HBV reactivation rate was high in patients treated with belatacept when compared with previous transplantation studies. HBV reactivation did not impact survival. Further studies are needed to confirm these results. A systematic antiviral prophylaxis for these patients should be considered and evaluated.

查看译文

关键词

Belatacept,HBcAb-positive,HBV reactivation,Hepatitis B virus,kidney transplantation

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要